Cart
sales@molnova.com
DLIN-MC2-DMA
CAS No. 1221271-55-1
DLIN-MC2-DMA( —— )
Catalog No. M37349 CAS No. 1221271-55-1
DLIN-MC2-DMA (DLin-M-C2-DMA) is a lipid membrane and a potential nucleic acid carrier.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 119 | In Stock |
|
| 50MG | 192 | In Stock |
|
| 100MG | 310 | In Stock |
|
| 200MG | 462 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDLIN-MC2-DMA
-
NoteResearch use only, not for human use.
-
Brief DescriptionDLIN-MC2-DMA (DLin-M-C2-DMA) is a lipid membrane and a potential nucleic acid carrier.
-
DescriptionDLin-M-K-DMA (DLin-M-C2-DMA) is a cationic lipid that can be used in the construction of biological delivery vectors.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1221271-55-1
-
Formula Weight628.07
-
Molecular FormulaC42H77NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (159.22 mM; Ultrasonic )
-
SMILESC(OC(CCN(C)C)=O)(CCCCCCCC/C=C\C/C=C\CCCCC)CCCCCCCC/C=C\C/C=C\CCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Ebopiprant
Ebopiprant (OBE022) is an orally available, selective and potent prostaglandin F2α (PGF2α) receptor antagonist that interferes with the binding of PGF0126α to the FPR and can be used in the study of obesity.
-
(2-Aminoethyl)phosph...
The specific growth rates of C. raciborskii cells in media treated with β-glycerol phosphate, d-glucose-6-phosphate, and (2-aminoethyl)phosphinic acid are significantly higher than those of cells grown in phosphorus free media.
-
Oleanic aldehyde
Oleanolic aldehyde is an antimicrobial compound used to inhibit oral bacteria. Oleanolic aldehyde inhibits Streptococcus mutans and Porphyromonas gingivalis, which are associated with dental caries and periodontal disease, with minimum inhibitory concentrations (MICs) of 488 μg/mL and 250 μg/mL, respectively.
